Details for Patent: 12,128,036
✉ Email this page to a colleague
Which drugs does patent 12,128,036 protect, and when does it expire?
Patent 12,128,036 protects VIZZ and is included in one NDA.
This patent has twenty-four patent family members in eleven countries.
Summary for Patent: 12,128,036
| Title: | Compositions and methods for storage stable ophthalmic drugs |
| Abstract: | The present invention is related to methods of stabilizing an ophthalmic drug by adding a surfactant and a viscosity enhancer to the ophthalmic drug to create a composition wherein the composition has a viscosity of about 25 centipoise or less at a shear rate of 1/1000 per second at 25 degrees Celsius and a viscosity of about 70 centipoise or more at shear rate of 1 per second at 25 degrees Celsius, filling the composition into a container; and storing the container at a temperature from about 2 degrees Celsius to about 25 degrees Celsius. The present invention is further directed to a container prepared by the methods of the present invention. |
| Inventor(s): | Gerald Horn |
| Assignee: | Lenz Therapeutics Operations Inc |
| Application Number: | US18/239,087 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 12,128,036
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lenz Therap | VIZZ | aceclidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 218585-001 | Jul 31, 2025 | RX | Yes | Yes | 12,128,036 | ⤷ Start Trial | TREATMENT OF PRESBYOPIA | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,128,036
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019357979 | ⤷ Start Trial | |||
| Australia | 2021361731 | ⤷ Start Trial | |||
| Australia | 2025279633 | ⤷ Start Trial | |||
| Brazil | 112021006618 | ⤷ Start Trial | |||
| Canada | 3114204 | ⤷ Start Trial | |||
| Canada | 3195422 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
